Literature DB >> 24476664

Crouzono-dermo-skeletal syndrome, Crouzon syndrome with acanthosis nigricans syndrome.

T E Herman1, K Sargar1, M J Siegel1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24476664     DOI: 10.1038/jp.2013.139

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


× No keyword cloud information.
  6 in total

1.  Atypical Crouzon syndrome with a novel Cys62Arg mutation in FGFR2 presenting with sagittal synostosis.

Authors:  Vikram P Sharma; Steven A Wall; Helen Lord; Tracy Lester; Andrew O M Wilkie
Journal:  Cleft Palate Craniofac J       Date:  2011-11-25

2.  Crouzon syndrome with acanthosis nigricans: a case-based update.

Authors:  Federico Di Rocco; Corinne Collet; Laurence Legeai-Mallet; Eric Arnaud; Martine Le Merrer; Smail Hadj-Rabia; Dominique Renier
Journal:  Childs Nerv Syst       Date:  2010-12-07       Impact factor: 1.475

3.  Crouzon syndrome with acanthosis nigricans: case report and mutational analysis.

Authors:  T Nagase; M Nagase; S Hirose; K Ohmori
Journal:  Cleft Palate Craniofac J       Date:  2000-01

4.  Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3.

Authors:  D N Schweitzer; J M Graham; R S Lachman; E W Jabs; K Okajima; K A Przylepa; A Shanske; K Chen; J A Neidich; W R Wilcox
Journal:  Am J Med Genet       Date:  2001-01-01

Review 5.  The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.

Authors:  Z Vajo; C A Francomano; D J Wilkin
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

6.  Crouzon with acanthosis nigricans. Further delineation of the syndrome.

Authors:  L Arnaud-López; R Fragoso; J Mantilla-Capacho; P Barros-Núñez
Journal:  Clin Genet       Date:  2007-11       Impact factor: 4.438

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.